Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NINDS

SINGLE-SHOT SPIRAL SCANNING MAGNETIC RESONANCE IMAGING USING TRAPEZOIDAL GRADIENTS

  • Read more about SINGLE-SHOT SPIRAL SCANNING MAGNETIC RESONANCE IMAGING USING TRAPEZOIDAL GRADIENTS
US Application 60/067,670
Filed on 1997-12-05

GENES FOR NIEMANN-PICK TYPE C DISEASE

  • Read more about GENES FOR NIEMANN-PICK TYPE C DISEASE
US Application 60/051,682
Filed on 1997-07-03

USE OF MARROW-DERIVED GLIAL PROGENITORS CELLS AS GENE DELIVERY VECHICLES INTO THE CENTRAL NERVOUS SYSTEM

  • Read more about USE OF MARROW-DERIVED GLIAL PROGENITORS CELLS AS GENE DELIVERY VECHICLES INTO THE CENTRAL NERVOUS SYSTEM
US Application 60/036,592
Filed on 1997-04-10

METHOD AND APPARATUS FOR REDUCING ARTIFACTS IN DIFFUSION-WEIGHTED IMAGES

  • Read more about METHOD AND APPARATUS FOR REDUCING ARTIFACTS IN DIFFUSION-WEIGHTED IMAGES
US Application 60/040,200
Filed on 1997-03-06

METHOD AND APPARATUS FOR ANALYZING AND DISPLAYING DIFFUSION TENSOR MAGNETIC RESONANCE IMAGING DATA

  • Read more about METHOD AND APPARATUS FOR ANALYZING AND DISPLAYING DIFFUSION TENSOR MAGNETIC RESONANCE IMAGING DATA
US Application 60/043,858
Filed on 1997-04-11

METHOD OF REDUCING PERIVASCULAR LESIONS USING INSULIN-LIKE GROWTH FACTOR I

  • Read more about METHOD OF REDUCING PERIVASCULAR LESIONS USING INSULIN-LIKE GROWTH FACTOR I
US Application 60/021,060
Filed on 1996-07-02

IMMUNOTOXIN (MAB-RICIN) FOR THE TREATMENT OF FOCAL MOVEMENT DISORDERS

  • Read more about IMMUNOTOXIN (MAB-RICIN) FOR THE TREATMENT OF FOCAL MOVEMENT DISORDERS
US Application 60/027,458
Filed on 1996-09-19

METHOD OF TREATING DEMYELINATING DISEASES WITH INSULIN-LIKE GROWTH FACTOR I

  • Read more about METHOD OF TREATING DEMYELINATING DISEASES WITH INSULIN-LIKE GROWTH FACTOR I
US Application 60/003,055
Filed on 1995-08-31

RECOMBINANT POLYPEPTIDES COMPRISING SINGLE-DOMAIN ANTIBODIES TARGETING HERV-K SUBTYPE HML-2

  • Read more about RECOMBINANT POLYPEPTIDES COMPRISING SINGLE-DOMAIN ANTIBODIES TARGETING HERV-K SUBTYPE HML-2
European Patent
23726799.2
Filed on 2024-09-08

RECOMBINANT POLYPEPTIDES COMPRISING SINGLE-DOMAIN ANTIBODIES TARGETING HERV-K SUBTYPE HML-2

  • Read more about RECOMBINANT POLYPEPTIDES COMPRISING SINGLE-DOMAIN ANTIBODIES TARGETING HERV-K SUBTYPE HML-2
US Application 18/859,027
Filed on 2024-10-22

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • Page 25
  • …
  • Next page ››
  • Last page Last »
Subscribe to NINDS
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health